Does a “whiff” of mania in a major depressive episode shift treatment from a classical antidepressant to an atypical/second-generation antipsychotic?

Bipolar Disorders

Volumn 19, Issue 7, 2017, Pages 595-596

  Stahl, Stephen M ^a   Morrissette, Debbi Ann ^a  

^a NEUROSCIENCE EDUCATION INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; NEUROLEPTIC AGENT;

BIPOLAR DISORDER; CLINICAL EFFECTIVENESS; DSM-5; EVIDENCE BASED MEDICINE; HUMAN; MAJOR DEPRESSION; MANIA; NOTE; PRACTICE GUIDELINE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; TREATMENT INDICATION;

ANTIDEPRESSIVE AGENTS; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; DEPRESSIVE DISORDER, MAJOR; HUMANS;

EID: 85030029456     PISSN: 13985647     EISSN: 13995618     Source Type: Journal    
DOI: 10.1111/bdi.12542     Document Type: Note

References (5)

1. Stahl SM. Mixed up about how to diagnose and treat mixed features in major depressive episodes. CNS Spectrums. 2017;22:111-115.
2. Stahl SM, Morrissette DA, Faedda G, et al. Guidelines for the recognition and treatment of mixed depression. CNS Spectrums. 2017;22:203-219.
3. Takeshima M, Oka T. DSM-5-defined ‘mixed features’ and Benazzi's mixed depression: which is practically useful to discriminate bipolar disorder from unipolar depression in patients with depression. Psychiatry Clin Neurosci. 2015;69:109-16.
4. Malhi GS, Lampe L, Coulston CM, et al. Mixed state discrimination: a DSM problem that won't go away? J Affect Disord. 2014;158:8-10.
5. Malhi GS, Berk M, Morris G, et al. Mixed mood: the not so united states? Bipolar Disord. 2017;19:242-245.